Metronomic Chemotherapy: A Systematic Review of the Literature and Clinical Experience.


Journal

Journal of oncology
ISSN: 1687-8450
Titre abrégé: J Oncol
Pays: Egypt
ID NLM: 101496537

Informations de publication

Date de publication:
2019
Historique:
received: 27 04 2018
revised: 24 12 2018
accepted: 05 02 2019
entrez: 25 4 2019
pubmed: 25 4 2019
medline: 25 4 2019
Statut: epublish

Résumé

Metronomic chemotherapy, continuous and dose-dense administration of chemotherapeutic drugs with lowered doses, is being evaluated for substituting, augmenting, or appending conventional maximum tolerated dose regimens, with preclinical and clinical studies for the past few decades. To date, the principle mechanisms of its action include impeding tumoral angiogenesis and modulation of hosts' immune system, affecting directly tumor cells, their progenitors, and neighboring stromal cells. Its better toxicity profile, lower cost, and easier use are main advantages over conventional therapies. The evidence of metronomic chemotherapy for personalized medicine is growing, starting with unfit elderly patients and also for palliative treatment. The literature reviewed in this article mainly demonstrates that metronomic chemotherapy is advantageous for selected patients and for certain types of malignancies, which make it a promising therapeutic approach for filling in the gaps. More clinical studies are needed to establish a solidified role for metronomic chemotherapy with other treatment models in modern cancer management.

Identifiants

pubmed: 31015835
doi: 10.1155/2019/5483791
pmc: PMC6446118
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

5483791

Références

Int J Breast Cancer. 2014;2014:769790
pubmed: 24551455
Clin Breast Cancer. 2015 Aug;15(4):259-65
pubmed: 25933934
Breast Cancer Res Treat. 2012 Nov;136(1):169-78
pubmed: 23001754
Cancer Chemother Pharmacol. 2012 Jan;69(1):35-42
pubmed: 21590447
Anticancer Res. 2013 Aug;33(8):3487-94
pubmed: 23898124
Am J Clin Oncol. 1998 Oct;21(5):505-8
pubmed: 9781610
Lancet Oncol. 2013 May;14(6):e239-48
pubmed: 23639324
Ann Oncol. 2006 Feb;17(2):232-8
pubmed: 16322118
Breast. 2011 Aug;20(4):319-23
pubmed: 21397505
Cancer. 2000 Mar 15;88(6):1438-44
pubmed: 10717628
Angiogenesis. 2013 Apr;16(2):373-86
pubmed: 23143659
BMC Cancer. 2011 May 31;11:214
pubmed: 21627839
Clin Lymphoma Myeloma Leuk. 2010 Feb;10(1):51-5
pubmed: 20223729
Br J Cancer. 2015 Jan 6;112(1):52-60
pubmed: 25461806
Ann Transl Med. 2015 Nov;3(20):305
pubmed: 26697465
Cancer Chemother Pharmacol. 1994;33(6):527-9
pubmed: 8137464
Sci Transl Med. 2015 Apr 8;7(282):282ra50
pubmed: 25855496
Cancer. 2010 Apr 1;116(7):1751-6
pubmed: 20120033
Nat Rev Cancer. 2007 Nov;7(11):834-46
pubmed: 17957189
Cancer Biol Ther. 2007 Mar;6(3):313-7
pubmed: 17327701
Eur J Immunol. 2010 Dec;40(12):3317-20
pubmed: 21110315
Oncol Rep. 2003 Jul-Aug;10(4):885-9
pubmed: 12792740
Br J Cancer. 2008 Apr 22;98(8):1312-9
pubmed: 18362940
Sci Rep. 2017 Feb 13;7:42499
pubmed: 28211921
Gynecol Oncol. 2007 Nov;107(2):326-30
pubmed: 17706754
Cell Cycle. 2007 Mar 1;6(5):538-42
pubmed: 17351339
Br J Cancer. 2011 Jun 7;104(12):1822-7
pubmed: 21587257
Mol Cancer Ther. 2010 Jul;9(7):2068-78
pubmed: 20606044
J Clin Oncol. 2008 Jan 1;26(1):76-82
pubmed: 18165643
Cancer Res. 2009 Sep 1;69(17):6987-94
pubmed: 19706755
J Clin Oncol. 2014 May 1;32(13):1302-8
pubmed: 24637997
South Asian J Cancer. 2016 Apr-Jun;5(2):48-51
pubmed: 27275445
J Clin Oncol. 2010 Apr 20;28(12):2051-7
pubmed: 20308655
Cancer. 1996 Mar 15;77(6):1144-8
pubmed: 8635136
Cancer. 2014 Dec 15;120(24):3923-31
pubmed: 25111199
Cancer Immunol Immunother. 2012 Oct;61(10):1791-804
pubmed: 22426890
Br J Urol. 1993 Nov;72(5 Pt 1):625-8
pubmed: 10071550
Oncol Lett. 2010 Jan;1(1):73-79
pubmed: 22966259
J Palliat Med. 2007 Feb;10(1):61-6
pubmed: 17298255
J Urol. 2007 Jun;177(6):2136-40; discussion 2140
pubmed: 17509300
Oncol Rep. 1996 Nov;3(6):1169-72
pubmed: 21594532
Clin Genitourin Cancer. 2015 Aug;13(4):271-279
pubmed: 25704270
Cancer. 2011 Aug 15;117(16):3731-40
pubmed: 21815133
Clin Transl Oncol. 2008 Sep;10(9):583-6
pubmed: 18796376
J Cancer Res Clin Oncol. 1992;119(1):55-7
pubmed: 1400568
Breast J. 2012 Sep;18(5):470-4
pubmed: 22827581
Proc Natl Acad Sci U S A. 2009 Feb 17;106(7):2353-8
pubmed: 19168635
Cancer. 2008 Jan 15;112(2):331-9
pubmed: 18058810
Lung Cancer. 2010 Feb;67(2):188-93
pubmed: 19394109
Lancet. 2015 May 9;385(9980):1843-52
pubmed: 25862517
Cancer Treat Rev. 1993;19 Suppl C:27-33
pubmed: 8221713
South Asian J Cancer. 2016 Apr-Jun;5(2):52-5
pubmed: 27275446
Clin Breast Cancer. 2018 Feb;18(1):e143-e149
pubmed: 29174203
Int J Cancer. 2013 Nov 15;133(10):2464-72
pubmed: 23649709
Cancer Chemother Pharmacol. 2007 Aug;60(3):351-6
pubmed: 17111120
Gynecol Oncol. 2011 Dec;123(3):499-504
pubmed: 21955480
Cancer Lett. 2018 Sep 28;432:28-37
pubmed: 29885517
Asia Pac J Clin Oncol. 2017 Jun;13(3):204-211
pubmed: 27521286
Med Oncol. 2015 Jan;32(1):443
pubmed: 25519824
Blood. 1999 Dec 15;94(12):4143-55
pubmed: 10590059
Clin Breast Cancer. 2014 Feb;14(1):13-9
pubmed: 24268206
Anticancer Res. 2012 Feb;32(2):529-36
pubmed: 22287742
J Chemother. 2008 Oct;20(5):632-9
pubmed: 19028628
J Clin Oncol. 2009 Mar 20;27(9):1368-74
pubmed: 19204202
Exp Ther Med. 2011 Jul;2(4):579-584
pubmed: 22977543
Br J Cancer. 2003 Apr 7;88(7):1004-11
pubmed: 12671695
Ann Oncol. 2004 Oct;15(10):1543-50
pubmed: 15367416
Asian Pac J Cancer Prev. 2012;13(8):3973-6
pubmed: 23098502
South Asian J Cancer. 2016 Apr-Jun;5(2):59-62
pubmed: 27275448
Cancer Lett. 2017 Aug 1;400:276-281
pubmed: 28131905
J Gynecol Oncol. 2013 Jul;24(3):258-64
pubmed: 23875076
J Clin Oncol. 2001 Jan 15;19(2):577-83
pubmed: 11208853
J Neurooncol. 2010 Dec;100(3):407-15
pubmed: 20446016
Anticancer Drugs. 2012 Mar;23(3):326-34
pubmed: 22129512
Cancer Chemother Pharmacol. 2012 Oct;70(4):603-9
pubmed: 22890892
Oncotarget. 2017 Aug 24;8(44):75904-75913
pubmed: 29100279
Dig Liver Dis. 2015 Jun;47(6):518-22
pubmed: 25861840
Cancer Immunol Immunother. 2009 Oct;58(10):1627-34
pubmed: 19221744
J Clin Invest. 2000 Apr;105(8):1045-7
pubmed: 10772648
Indian J Cancer. 2013 Apr-Jun;50(2):122-7
pubmed: 23979203
J Cell Mol Med. 2012 Mar;16(3):425-36
pubmed: 21895966
Med Oncol. 2012 Jun;29(2):799-805
pubmed: 21607771
J Natl Cancer Inst. 1997 Dec 17;89(24):1892-3
pubmed: 9414178
South Asian J Cancer. 2016 Apr-Jun;5(2):67-9
pubmed: 27275452
J Clin Oncol. 2005 Feb 10;23(5):939-52
pubmed: 15557593
J Clin Oncol. 1994 May;12(5):986-91
pubmed: 8164052
Breast Cancer Res Treat. 2001 Dec;70(3):163-9
pubmed: 11804180
Am J Clin Dermatol. 2014 Aug;15(4):323-37
pubmed: 24928310
Cancer Chemother Pharmacol. 2013 Mar;71(3):741-7
pubmed: 23334260
BMC Cancer. 2015 May 06;15:359
pubmed: 25943747
Neuro Oncol. 2010 Mar;12(3):289-96
pubmed: 20167817
Bioessays. 1991 Jan;13(1):31-6
pubmed: 1722975
Cancer Chemother Pharmacol. 2015 Apr;75(4):821-7
pubmed: 25702051
Leuk Lymphoma. 2014 Oct;55(10):2271-6
pubmed: 24467219
Leuk Lymphoma. 2020 Sep;61(9):2208-2215
pubmed: 32812822
Breast Cancer Res Treat. 2016 Dec;160(3):501-509
pubmed: 27752847
Cancer Chemother Pharmacol. 2012 Feb;69(2):515-22
pubmed: 21874317
Invest New Drugs. 2010 Oct;28(5):684-9
pubmed: 19669699
Kaohsiung J Med Sci. 2014 Feb;30(2):82-5
pubmed: 24444537
J Cancer Res Clin Oncol. 2005 Jan;131(1):31-40
pubmed: 15565458
Ann Oncol. 2002 Jan;13(1):73-80
pubmed: 11863115
Int J Cancer. 2012 Jan 1;130(1):59-70
pubmed: 21384343
J Neurooncol. 2011 Jun;103(2):371-9
pubmed: 20853132
Biomed Pharmacother. 2004 Oct;58(8):447-50
pubmed: 15464874
Cancer Chemother Pharmacol. 2006 Sep;58(3):354-60
pubmed: 16333676
Stem Cells Int. 2015;2015:832649
pubmed: 26000021
Med Oncol. 2016 Aug;33(8):89
pubmed: 27400698
Prostate Int. 2016 Mar;4(1):15-9
pubmed: 27014659
Curr Oncol. 2012 Apr;19(2):e75-83
pubmed: 22514500
Br J Cancer. 2009 Dec 15;101(12):1986-94
pubmed: 19920819
Indian J Cancer. 2013 Apr-Jun;50(2):135-41
pubmed: 23979205
Cell Death Dis. 2013 Dec 12;4:e966
pubmed: 24336086
J Clin Oncol. 2009 Aug 10;27(23):3861-7
pubmed: 19506159
Cancer Chemother Pharmacol. 2012 Aug;70(2):331-8
pubmed: 22526409
BJU Int. 2008 Feb;101(4):440-3
pubmed: 17941935
Invest New Drugs. 2016 Dec;34(6):760-770
pubmed: 27557783
Oncologist. 2012;17(8):1063-72
pubmed: 22707516
Breast Cancer. 2015 Jul;22(4):335-42
pubmed: 23827973
Cancer Biol Ther. 2011 Jul 15;12(2):112-8
pubmed: 21525780
Indian J Cancer. 2017 Jan-Mar;54(1):25-29
pubmed: 29199656
Clin Lung Cancer. 2015 Nov;16(6):e229-34
pubmed: 26072097
Clin Cancer Res. 2009 Aug 1;15(15):4954-62
pubmed: 19622584
Asia Pac J Clin Oncol. 2017 Apr;13(2):e138-e143
pubmed: 26531225
Eur J Cancer. 1998 Jul;34(8):1274-81
pubmed: 9849491
Gynecol Oncol. 2010 Dec;119(3):444-50
pubmed: 20846715
Anticancer Drugs. 2006 Sep;17(8):961-7
pubmed: 16940806
Cancer. 2003 Oct 15;98(8):1643-8
pubmed: 14534880
Gynecol Oncol. 2015 Jun;137(3):392-400
pubmed: 25792179
Onkologie. 2008 Apr;31(4):185-9
pubmed: 18418020
Neuro Oncol. 2013 Feb;15(2):242-50
pubmed: 23243055
J Cancer Res Clin Oncol. 2012 Feb;138(2):333-9
pubmed: 22134838
N Engl J Med. 2011 Dec 29;365(26):2473-83
pubmed: 22204724
BMC Cancer. 2014 Mar 14;14:184
pubmed: 24628963
Oncology. 2012;82(1):59-66
pubmed: 22310088
Cancer Immunol Immunother. 2008 Nov;57(11):1579-87
pubmed: 18369619
Neuro Oncol. 2007 Jul;9(3):354-63
pubmed: 17452651
Hematol Oncol Stem Cell Ther. 2015 Mar;8(1):22-7
pubmed: 25528114
Eur J Neurol. 2013 Feb;20(2):223-30
pubmed: 22680781
Ann Oncol. 2010 Jun;21(6):1290-1295
pubmed: 19914959
Cancer. 2008 Nov 1;113(9):2524-31
pubmed: 18798231
South Asian J Cancer. 2016 Apr-Jun;5(2):63-6
pubmed: 27275450
J Korean Neurosurg Soc. 2015 Nov;58(5):426-31
pubmed: 26713142
BMC Cancer. 2007 Apr 15;7:65
pubmed: 17433113
Prostate. 2001 Mar 1;46(4):257-61
pubmed: 11241547
Tumori. 2015 Jan-Feb;101(1):30-5
pubmed: 25702645
Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12917-22
pubmed: 14561896
Semin Immunopathol. 2011 Jul;33(4):369-83
pubmed: 21611872
Nat Rev Clin Oncol. 2016 Nov;13(11):659-673
pubmed: 27184418
Indian J Med Paediatr Oncol. 2015 Jul-Sep;36(3):161-5
pubmed: 26855524
Future Oncol. 2013 Mar;9(3):451-62
pubmed: 23469980
Med Oncol. 2010 Jun;27(2):363-7
pubmed: 19365737
J Exp Clin Cancer Res. 2007 Dec;26(4):475-82
pubmed: 18365541
Cancer. 2003 Oct 15;98(8):1603-10
pubmed: 14534875
PLoS One. 2011;6(9):e24397
pubmed: 21935404
J Am Geriatr Soc. 2010 May;58(5):986-8
pubmed: 20722827
Int J Breast Cancer. 2011;2011:710292
pubmed: 22295231
Nat Rev Clin Oncol. 2010 Aug;7(8):455-65
pubmed: 20531380
Clin Breast Cancer. 2018 Feb;18(1):e135-e142
pubmed: 28935542
Indian J Cancer. 2013 Apr-Jun;50(2):128-34
pubmed: 23979204
Oncologist. 2007 Jan;12(1):99-106
pubmed: 17227904
Curr Opin Immunol. 2008 Oct;20(5):504-11
pubmed: 18573340
Oncotarget. 2015 Dec 15;6(40):42396-410
pubmed: 26623560
PLoS One. 2017 Mar 22;12(3):e0174280
pubmed: 28328969
Jpn J Clin Oncol. 2011 Feb;41(2):253-9
pubmed: 21071389
Clin Breast Cancer. 2010 Aug 1;10(4):301-6
pubmed: 20705563
Eur J Cancer. 2011 Mar;47(4):515-9
pubmed: 21251814
Clin Mol Hepatol. 2017 Jun;23(2):128-137
pubmed: 28494528
Thorac Cancer. 2013 Aug;4(3):234-240
pubmed: 28920253
Cancer Res. 2010 Apr 15;70(8):3052-61
pubmed: 20388795
J Chemother. 2010 Jun;22(3):201-4
pubmed: 20566427
Lung Cancer. 2017 Apr;106:125-130
pubmed: 28285686
Angiogenesis. 2012 Jun;15(2):275-86
pubmed: 22382585
Curr Top Med Chem. 2012;12(15):1639-42
pubmed: 22978340
Cancer Sci. 2013 Nov;104(11):1391-5
pubmed: 23930621
Oncogene. 2010 Aug 26;29(34):4741-51
pubmed: 20531305
Cell Oncol (Dordr). 2011 Apr;34(2):97-106
pubmed: 21290210
Biochem Pharmacol. 2018 Jun;152:327-337
pubmed: 29660315
J Hepatol. 2010 Jul;53(1):126-31
pubmed: 20416968
Lung Cancer. 2015 Jun;88(3):289-96
pubmed: 25896396
Cancer Res. 2011 Jul 15;71(14):4821-33
pubmed: 21602432
Cancer Res. 2002 Dec 1;62(23):6938-43
pubmed: 12460910
J Chemother. 2013 Feb;25(1):49-55
pubmed: 23433445
Anticancer Res. 2010 Oct;30(10):4317-23
pubmed: 21036758
N Engl J Med. 1999 Nov 18;341(21):1565-71
pubmed: 10564685
Nature. 2001 Nov 1;414(6859):105-11
pubmed: 11689955
Med Oncol. 2015 Mar;32(3):54
pubmed: 25638466
Oncogene. 2005 Dec 1;24(54):8025-37
pubmed: 16116481
Anticancer Drugs. 1996 Jul;7(5):543-7
pubmed: 8862722
CA Cancer J Clin. 2014 Jan-Feb;64(1):52-62
pubmed: 24114568
J Interferon Cytokine Res. 2015 May;35(5):367-72
pubmed: 25474369
Br J Cancer. 2013 Aug 20;109(4):957-64
pubmed: 23860526
PLoS One. 2013 Dec 04;8(12):e81858
pubmed: 24324725
J Chemother. 2006 Apr;18(2):188-91
pubmed: 16736888
Curr Oncol. 2017 Jun;24(3):e199-e204
pubmed: 28680287
Ecancermedicalscience. 2014 Sep 09;8:463
pubmed: 25228919
Biomark Med. 2014;8(6):893-911
pubmed: 25224945
Clin Cancer Res. 2012 Feb 1;18(3):645-53
pubmed: 22156560
Cancer Res. 2003 Aug 1;63(15):4342-6
pubmed: 12907602
Gynecol Oncol. 2017 Aug;146(2):279-284
pubmed: 28528917
Clin Breast Cancer. 2017 Dec;17(8):618-628
pubmed: 28625341
Cancer Immunol Immunother. 2007 May;56(5):641-8
pubmed: 16960692
Ann Transl Med. 2015 Nov;3(19):284
pubmed: 26697444
Clin Cancer Res. 1999 Mar;5(3):587-91
pubmed: 10100710
J Biochem. 2013 Mar;153(3):243-9
pubmed: 23293323
Br J Haematol. 2015 Jan;168(1):46-54
pubmed: 25146584
CA Cancer J Clin. 2015 Mar;65(2):87-108
pubmed: 25651787
Target Oncol. 2009 Apr;4(2):143-7
pubmed: 19377851
Haematologica. 2013 Jul;98(7):1147-53
pubmed: 23716540
Clin Genitourin Cancer. 2014 Oct;12(5):e197-203
pubmed: 24674784
Oncol Rep. 2006 Jul;16(1):133-40
pubmed: 16786136
Ann Oncol. 2010 Aug;21(8):1723-1727
pubmed: 20064829
Lancet Oncol. 2010 Apr;11(4):350-7
pubmed: 20163987
Medicine (Baltimore). 2015 May;94(17):e774
pubmed: 25929919
J BUON. 2011 Apr-Jun;16(2):215-8
pubmed: 21766488
Int J Cancer. 2013 Aug 1;133(3):624-36
pubmed: 23364915
Korean J Hepatol. 2012 Mar;18(1):32-40
pubmed: 22511901
Eur J Cancer. 2013 Nov;49(16):3387-95
pubmed: 23880474
Cell Immunol. 2010;261(2):134-43
pubmed: 20036354
Lymphat Res Biol. 2008;6(3-4):203-7
pubmed: 19093793
Tumori. 2010 Nov-Dec;96(6):1028-30
pubmed: 21388070
Oncology. 2009;76(2):112-7
pubmed: 19142045
Oncologist. 2013;18(12):1256-7
pubmed: 24232581
Lung Cancer. 2009 Dec;66(3):333-7
pubmed: 19327865
Oncotarget. 2017 Jun 16;8(45):79527-79536
pubmed: 29108332
Indian J Cancer. 2018 Jan-Mar;55(1):94-97
pubmed: 30147102
Cancer Res. 2000 Apr 1;60(7):1878-86
pubmed: 10766175
Neoplasia. 2014 Jun;16(6):501-10
pubmed: 24957319
Anticancer Drugs. 2016 Feb;27(2):106-11
pubmed: 26473528
Breast Cancer Res Treat. 1995 May;34(2):185-9
pubmed: 7647335
Oncology. 2010;79(1-2):98-104
pubmed: 21079407
J Clin Epidemiol. 2009 Oct;62(10):1006-12
pubmed: 19631508
Ann Oncol. 2016 Jan;27(1):140-7
pubmed: 26483047
Med Oncol. 2012 Mar;29(1):100-6
pubmed: 21264547
Blood. 2016 Nov 10;128(19):2297-2306
pubmed: 27647864
Oncology. 2001;60(1):49-54
pubmed: 11150908
Urology. 2011 Nov;78(5):1125-30
pubmed: 22054386
Mol Ther. 2010 Jun;18(6):1233-43
pubmed: 20372107
Stem Cells Dev. 2012 Mar 1;21(4):503-6
pubmed: 21933025
Cancer Res. 2007 Jan 1;67(1):281-8
pubmed: 17210709
Clin Exp Metastasis. 2015 Feb;32(2):111-24
pubmed: 25617965
BMC Cancer. 2014 Dec 13;14:947
pubmed: 25495785

Auteurs

Cem Simsek (C)

Department of Internal Medicine, Hacettepe University, Ankara, Turkey.

Ece Esin (E)

Department of Medical Oncology, A.Y. Ankara Training Hospital, Ankara, Turkey.

Suayib Yalcin (S)

Department of Medical Oncology, Hacettepe University, Ankara, Turkey.

Classifications MeSH